Research Topic · Peer-Reviewed

Pharmacogenomics

Pharmacogenomics is the study of how an individual’s genes affect their response to medications. By understanding the genetic basis of drug response and toxicity, pharmacogenomics can personalize drug therapies to optimize treatment outcomes and reduce the risk of adverse drug reactions. It has become a useful tool …

Curated from this journal's research 📚 1 peer-reviewed article cited 🗓 Reviewed June 2026

Overview

Pharmacogenomics is the study of how an individual’s genes affect their response to medications. By understanding the genetic basis of drug response and toxicity, pharmacogenomics can personalize drug therapies to optimize treatment outcomes and reduce the risk of adverse drug reactions. It has become a useful tool for doctors to recommend the most effective and safest medications for their patients based on their genetic makeup. This helps to ensure the best treatment decisions and ultimately improve patient health outcomes.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

Editorial oversight

Curated from peer-reviewed research published in Schizophrenia Disorders And Therapy.

Journal editorial board
Olaoluwa Okusaga · United States Andrea de Bartolomeis · Italy Krzysztof Krysta · Poland

This page summarises published research for orientation; it is not medical or professional advice.